Arthur He
Stock Analyst at HC Wainwright & Co.
(4.07)
# 619
Out of 5,113 analysts
47
Total ratings
53.06%
Success rate
16.13%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Arthur He
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| JBIO Jade Biosciences | Initiates: Buy | $25 | $16.02 | +56.05% | 1 | Jan 7, 2026 | |
| NKTR Nektar Therapeutics | Maintains: Buy | $120 → $135 | $38.03 | +254.98% | 5 | Dec 16, 2025 | |
| VERA Vera Therapeutics | Maintains: Buy | $85 → $90 | $46.75 | +92.51% | 3 | Nov 10, 2025 | |
| ADAG Adagene | Maintains: Buy | $8 → $7 | $2.49 | +181.12% | 11 | Aug 15, 2025 | |
| AUPH Aurinia Pharmaceuticals | Assumes: Buy | $17 | $14.57 | +16.68% | 1 | Jul 30, 2025 | |
| SLDB Solid Biosciences | Reiterates: Buy | $20 | $6.57 | +204.41% | 10 | Jun 17, 2025 | |
| PRME Prime Medicine | Downgrades: Neutral | n/a | $4.28 | - | 8 | May 20, 2025 | |
| BCAB BioAtla | Reiterates: Neutral | n/a | $0.33 | - | 8 | Mar 31, 2025 |
Jade Biosciences
Jan 7, 2026
Initiates: Buy
Price Target: $25
Current: $16.02
Upside: +56.05%
Nektar Therapeutics
Dec 16, 2025
Maintains: Buy
Price Target: $120 → $135
Current: $38.03
Upside: +254.98%
Vera Therapeutics
Nov 10, 2025
Maintains: Buy
Price Target: $85 → $90
Current: $46.75
Upside: +92.51%
Adagene
Aug 15, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $2.49
Upside: +181.12%
Aurinia Pharmaceuticals
Jul 30, 2025
Assumes: Buy
Price Target: $17
Current: $14.57
Upside: +16.68%
Solid Biosciences
Jun 17, 2025
Reiterates: Buy
Price Target: $20
Current: $6.57
Upside: +204.41%
Prime Medicine
May 20, 2025
Downgrades: Neutral
Price Target: n/a
Current: $4.28
Upside: -
BioAtla
Mar 31, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.33
Upside: -